Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: J Nucl Cardiol. 2019 May 9;28(2):688–694. doi: 10.1007/s12350-019-01724-w

Table 1:

Clinical characteristics and laboratory data of the subjects

Control (n = 7) PTSD (n = 8) p-value
Age (years) 34 ± 8 34 ± 7 0.94
Male sex 5(71) 5 (63) 0.71
Current smoker 3 (43) 2(25) 0.58
BMI 30 ± 3 31 ± 6 0.82
Systolic BP (mmHg) 132 ± 10 125 ± 12 0.24
Diastolic BP (mmHg) 83 ± 6 83 ± 10 0.95
Total cholesterol (mg/dL) 191 ± 45 210 ± 47 0.44
LDL-C (mg/dL) 121 ± 36 130 ± 43 0.69
HDL-C (mg/dL) 46 ± 10 49 ± 13 0.67
Triglycerides (mg/dL) 119 ± 44 160 ± 76 0.23
Creatinine (mg/dL) 0.56 ± 1.08 0.49 ± 1.01 0.39*
Glucose (mg/dL) 95 ± 5 92 ± 11 0.50
PCL-5 score 3 ± 4 34 ± 12 <0.0001
Time since index event (year) n/a 15 ± 13 n/a

Values are mean ± SD or n (%). BMI: body mass index; BP: Blood pressure; LDL-C: low density lipoprotein- cholesterol; HDL-C: high density lipoprotein-cholesterol; PCL-5: PTSD checklist for DSM-5.

*:

Mann- Whitney U test.